ADENOVIRUS IL-12 AND DOCETAXEL IN COMBINATION WITH ANTI-PD1 AS AN EFFECTIVE TREATMENT STRATEGY FOR TNBC

被引：0
|
作者：
Qian, Wei [1 ]
Zhou, Jianying [1 ]
Rosato, Roberto [1 ]
Chang, Jenny [1 ]
Anselme, Ann [1 ]
机构：
[1] Houston Methodist Res Inst, Houston, TX USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2020年 / 8卷
关键词：
D O I：
10.1136/jitc-2020-SITC2020.0437
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
437
引用
收藏
页码：A266 / A266
页数：1
相关论文
共 50 条
  • [1] Pre-treating TNBC with docetaxel and il-12 enhances anti-PD1 efficacy
    Anselme, Ann Cassany
    Qian, Wei
    Zhou, Jianying
    Rosato, Roberto R.
    Chang, Jenny C.
    CANCER RESEARCH, 2021, 81 (04)
  • [2] T-cell Enriching Therapy using combination of IL-12 gene electrotransfer and anti-PD-1 attenuates the resistance of anti-PD1 in preclinical metastatic cancer
    Shi, Guilan
    Scott, Megan
    Lundberg, Cathryn
    Heller, Richard
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [3] PD-1 peptide/IL-12 combination gene therapy for the treatment of melanoma
    Heller, Loree
    Shi, Guilan
    Synowiec, Jody
    Heller, Richard
    CANCER RESEARCH, 2022, 82 (12)
  • [4] IL-12 and PD-1 peptide combination gene therapy for the treatment of melanoma
    Heller, Loree C.
    Shi, Guilan
    Conniff, Amanda Sales
    Singh, Julie
    Mannarino, Samantha
    Synowiec, Jody
    Heller, Richard
    MOLECULAR THERAPY NUCLEIC ACIDS, 2024, 35 (03):
  • [5] A SINGLE SPARK CAN START A PRAIRIE FIRE - RETHINK THE COMBINATION STRATEGY AND CLINICAL SETTING OF IL-12 WITH ANTI-PD-1
    Tsou, Pei-Yi
    Lin, Wan-Ying
    Lee, Meng-Na
    Chen, San-Chi
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1145 - A1145
  • [6] AAV Mediated Expression of Mouse IL-12 Shows Potent Anti-Tumor Activity and Immune Response Alone and in Combination with Anti-PD1 in Syngeneic Murine Tumor Models
    Sutton, David
    Prentiss, Pilar
    Furmanski, Brian
    MOLECULAR THERAPY, 2022, 30 (04) : 161 - 161
  • [7] Combination of recombinant murine IL-12 and anti-PD-1 induced synergistic anti-tumor response.
    Tsou, Peiyi
    Lin, Wan-Ying
    Lee, Meng-Na
    Chen, San-Chi
    CANCER RESEARCH, 2022, 82 (12)
  • [8] Kinase inhibition and anti-PD1 combination therapy
    Collingridge, David
    LANCET ONCOLOGY, 2020, 21 (07): : 886 - 886
  • [9] IMMUNE PRESSURE IN AN ADVANCED HEPATOCELLULAR CANCER PATIENT FOLLOWING TREATMENT WITH PERSONALIZED NEOANTIGEN DNA VACCINE (GNOS-PV02) IN COMBINATION WITH PLASMID IL-12 (PIL12) AND ANTI-PD1 (PEMBROLIZUMAB)
    Yarchoan, Mark
    Gane, Edward
    Perales, Renzo
    Perales-Puchalt, Alfredo
    Bartha, Gabor
    Rochestie, Sarah
    Cooch, Neil
    Peters, Joann
    Csiki, Ildiko
    Yan, Jian
    Sardesai, Niranjan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A722 - A722
  • [10] Review of the Combination Strategies Used in Anti-PD1/PD-L1 Monoclonal Antibody Treatment
    Cheng, Jiaxing
    2020 INTERNATIONAL CONFERENCE ON ENERGY, ENVIRONMENT AND BIOENGINEERING (ICEEB 2020), 2020, 185
12345